Search research articles
Contact Us
Filters
Showing results (31-40 of 43) with videos related to
Page
of 5
Sort By:
Frontiers in Cardiovascular Medicine
|
May 16, 2022
Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases
Marco D'Agostino, Sara Beji, Sara Sileno, et al.
Aging
|
April 18, 2020
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21
Laura Mercurio, Daniela Lulli, Francesca Mascia, et al.
Cell Death & Disease
|
November 1, 2018
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
Laura Mercurio, Martina Morelli, Claudia Scarponi, et al.
The Journal of Pathology. Clinical Research
|
October 3, 2019
Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development
Luca Fania, Martina Morelli, Claudia Scarponi, et al.
Frontiers in Immunology
|
April 27, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases
Giulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, et al.
Life (Basel, Switzerland)
|
November 27, 2025
Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis
Giuseppe Annunziata, Emanuele Scala, Laura Mercurio, et al.
The British Journal of Dermatology
|
April 17, 2026
The nerve growth factor receptor p75NTR interacts with toll like receptor 4 and the alarmins high mobility group box-1 and nucleophosmin: a novel inflammatory mechanism in psoriasis
Sara Sileno, Marco D'Agostino, Luciapia Farina, et al.
Human Molecular Genetics
|
September 11, 2021
Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species
Giovanna Carpentieri, Chiara Leoni, Donatella Pietraforte, et al.
Frontiers in Immunology
|
July 31, 2025
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients
Roberta Belli, Anna Dattolo, Francesca Sampogna, et al.
Frontiers in Immunology
|
April 27, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy
Martina Morelli, Giovanni Luca Scaglione, Anna Dattolo, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 43) with videos related to
Sort By:
Page
of 5
Frontiers in Cardiovascular Medicine
|
May 16, 2022
Extracellular Nucleophosmin Is Increased in Psoriasis and Correlates With the Determinants of Cardiovascular Diseases
Marco D'Agostino, Sara Beji, Sara Sileno, et al.
Aging
|
April 18, 2020
Intracellular Insulin-like growth factor binding protein 2 (IGFBP2) contributes to the senescence of keratinocytes in psoriasis by stabilizing cytoplasmic p21
Laura Mercurio, Daniela Lulli, Francesca Mascia, et al.
Cell Death & Disease
|
November 1, 2018
IL-38 has an anti-inflammatory action in psoriasis and its expression correlates with disease severity and therapeutic response to anti-IL-17A treatment
Laura Mercurio, Martina Morelli, Claudia Scarponi, et al.
The Journal of Pathology. Clinical Research
|
October 3, 2019
Paradoxical psoriasis induced by TNF-α blockade shows immunological features typical of the early phase of psoriasis development
Luca Fania, Martina Morelli, Claudia Scarponi, et al.
Frontiers in Immunology
|
April 27, 2026
CXCL13 as a simple and promising blood biomarker for differentiating Sézary syndrome from mycosis fungoides and other confounding chronic inflammatory skin diseases
Giulia Salvatore, Ylenia Aura Minafò, Nicoletta Croce, et al.
Life (Basel, Switzerland)
|
November 27, 2025
Anti-IL-17 and Anti-IL-23 Therapies Modulate Serum Biomarkers of Intestinal Dysbiosis and Oxidative Stress Linked to Cardiovascular Risk in Patients with Psoriasis
Giuseppe Annunziata, Emanuele Scala, Laura Mercurio, et al.
The British Journal of Dermatology
|
April 17, 2026
The nerve growth factor receptor p75NTR interacts with toll like receptor 4 and the alarmins high mobility group box-1 and nucleophosmin: a novel inflammatory mechanism in psoriasis
Sara Sileno, Marco D'Agostino, Luciapia Farina, et al.
Human Molecular Genetics
|
September 11, 2021
Hyperactive HRAS dysregulates energetic metabolism in fibroblasts from patients with Costello syndrome via enhanced production of reactive oxidizing species
Giovanna Carpentieri, Chiara Leoni, Donatella Pietraforte, et al.
Frontiers in Immunology
|
July 31, 2025
Leptin: a gender and obesity-related marker predictive of metabolic comorbidities and therapeutic response to anti-IL-23 biologic drugs in psoriatic patients
Roberta Belli, Anna Dattolo, Francesca Sampogna, et al.
Frontiers in Immunology
|
April 27, 2026
Genetic profiling of patients with atopic dermatitis reveals immune and skin barrier variants associated with generalized eczema and optimal response to Dupilumab therapy
Martina Morelli, Giovanni Luca Scaglione, Anna Dattolo, et al.
Page
of 5